Research across Community-Acquired Pneumonia
Related studies from across the Community-Acquired Pneumonia family.
Systemic corticosteroid therapy significantly decreased length of hospital stay and fever duration in children with community-acquired pneumonia
Shorter hospital stays and fever for kids with pneumonia using steroids
This systematic review and meta-analysis evaluated systemic corticosteroid therapy versus controls in children with community-acquired pneum…
A large review found that adding steroids to standard antibiotics helped children with pneumonia leave the hospital faster and get over thei…
High mortality rates observed in community-acquired pneumonia patients within intensive care units across low- and middle-income regions
Community-acquired pneumonia kills one in three ICU patients in low- and middle-income countries
A systematic review and meta-analysis of 48,707 patients reveals stark mortality risks for community-acquired pneumonia in resource-limited …
A massive review shows that one in three patients with pneumonia admitted to ICUs in low- and middle-income countries dies within a month.
Meta-analysis finds no clear difference between amoxicillin and other antibiotics for community-acquired pneumonia
Doctors find amoxicillin works just as well as other drugs for pneumonia
A systematic review and meta-analysis compared amoxicillin and amoxicillin-clavulanate to other antibiotics for community-acquired pneumonia…
New research shows a common antibiotic called amoxicillin works just as well as other options for treating pneumonia in people of all ages.
Hospitalized children with HMPV infection had 28.0% severe CAP rates and higher risks of wheezing and co-infection
Premature birth and wheezing raise severe HMPV pneumonia risk
This retrospective cohort study examined 878 hospitalized children with human metapneumovirus (HMPV)-positive community-acquired pneumonia (…
A study of 878 children finds premature birth and wheezing are strong predictors of severe HMPV pneumonia.
Nemonoxacin shows similar efficacy to moxifloxacin in hospitalized CAP patients
New pneumonia drug saves money while matching standard care results
This retrospective cohort study of 196 hospitalized patients with community-acquired pneumonia found that nemonoxacin injection had 100.0% c…
A new pneumonia drug saves hospital costs while working just as well as the standard treatment for patients.
Macrolide-resistant Mycoplasma pneumoniae prevalence at 94% in pediatric CAP cohort
Resistant pneumonia keeps kids sicker for days
This retrospective cohort of 71 pediatric patients in China found a 94.4% prevalence of macrolide-resistant M.
In one Chinese hospital, 94% of child pneumonia cases resisted common antibiotics, leading to longer fevers and hospital stays.
Machine learning models outperformed APACHE-II for predicting mortality in severe community-acquired pneumonia patients with respiratory failure
Machine learning models may predict pneumonia death risk better than standard scores in ICU patients
This retrospective cohort study evaluated machine learning models versus the Acute Physiology and Chronic Health Evaluation II (APACHE-II) s…
New computer models predict pneumonia death risk in ICU patients more accurately than standard scores doctors currently use.
tNGS in pediatric LRTIs shows higher Mycoplasma pneumoniae detection in severe vs non-severe CAP
A new test found more germs in severe pediatric pneumonia cases than mild ones
A retrospective, single-center cohort study of 2,299 children with suspected lower respiratory tract infections found that targeted next-gen…
A new test found that severe pediatric pneumonia cases carry more germs than mild ones, revealing a link between specific microbial signatur…
Systemic Immune-Inflammation Index predicts severe community-acquired pneumonia in pediatric patients
High Blood Markers Signal Dangerous Pneumia in Kids
This retrospective analysis evaluated 595 pediatric patients to assess the Systemic Immune-Inflammation Index (SII) for predicting severe pn…
A simple blood test number called SII helps doctors spot dangerous pneumonia in children before their lungs fill with fluid.
Pyroptosis endotypes and malnutrition linked to mortality in older adults with community-acquired pneumonia
High inflammation markers linked to higher death risk in older pneumonia patients
This retrospective cohort study evaluated 282 hospitalized older adults (aged ≥75 years) with community-acquired pneumonia.
Older pneumonia patients with high inflammation markers faced a 57.5% death risk, while those with low levels had only 1.2% mortality within…
Immune dysregulation score predicts mortality and identifies hydrocortisone responders in community-acquired pneumonia
Three Blood Markers May Pick Who Benefits From Sepsis Steroids
A multicohort analysis and reanalysis of an RCT developed and validated an immune dysregulation score using three plasma biomarkers in 398 d…
A simple three-blood-test model may finally pick which sepsis patients benefit most from steroid treatment, using biology instead of guesswo…
Contezolid shows 80% clinical cure rate in small pneumonia study with good pulmonary penetration
Can a new oral antibiotic effectively treat pneumonia?
A prospective, single-center, open-label study of 15 adults with primarily community-acquired pneumonia found oral contezolid 800 mg twice d…
A new oral antibiotic called contezolid cured pneumonia in 80% of patients and reached lung infection sites at levels four times higher than…